UNIVERSAL HEALTH SERVICES INC
424B3, 2001-01-19
GENERAL MEDICAL & SURGICAL HOSPITALS, NEC
Previous: UNIGENE LABORATORIES INC, S-1, EX-27, 2001-01-19
Next: ICO INC, DEFA14A, 2001-01-19



<PAGE>

                                        Filed Pursuant to Rule 424(b)(3) and (c)
                                                   Registration Number 333-46098

PROSPECTUS SUPPLEMENT
(to prospectus dated November 2, 2000
and supplemented November 9, 2000,
November 21, 2000, November 29, 2000,
December 13, 2000 and January 11, 2001)


                                 $586,992,000

                        UNIVERSAL HEALTH SERVICES, INC.

                        CONVERTIBLE DEBENTURES DUE 2020
                                      AND
                         CLASS B COMMON STOCK ISSUABLE
                       UPON CONVERSION OF THE DEBENTURES


     This prospectus supplement supplements the prospectus dated November 2,
2000 and supplemented November 9, 2000, November 21, 2000, November 29, 2000,
December 13, 2000 and January 11, 2001 (the "prospectus") of Universal Health
Services, Inc. ("UHS" or "our") relating to the sale by certain of our
securityholders or by their transferees, pledgees, donees or other successors
(the "selling securityholders") of up to $586,992,000 principal amount at
maturity of UHS's convertible debentures due 2020 (the "debentures") and the
shares of our class B common stock issuable upon conversion of the debentures.
You should read this prospectus supplement in conjunction with the prospectus,
and this prospectus supplement is qualified by reference to the prospectus
except to the extent that the information in this prospectus supplement
supersedes the information contained in the prospectus.

                            SELLING SECURITYHOLDERS

     The following table provides certain information with respect to the
principal amount at maturity of debentures beneficially owned by entities who
were identified as selling securityholders in the prospectus for whom the
information set forth in the prospectus has changed, the percentage of
outstanding debentures held by each such entity, and the number of shares of our
class B common stock issuable upon conversion of such outstanding debentures.
All information concerning beneficial ownership of the debentures has been
furnished to UHS by the selling securityholders.  The table of selling
securityholders in the prospectus is hereby amended as set forth below with
respect to the information provided for "Lydian Overseas Partners Master Fund",
"Van Kampen Harbor Fund", and "Any other holder of debentures or future
transferee, pledgee, donee or successor of any holder".

<TABLE>
<CAPTION>
                                                          Principal Amount at      Percentage of    Number of Shares of
                                                        Maturity of Debentures      Debentures      Class B Common Stock
                       Name                                That May Be Sold         Outstanding       That May Be Sold
                       ----                             ----------------------    ---------------   --------------------
<S>                                                     <C>                        <C>              <C>
Lydian Overseas Partners Master Fund...............          $ 45,207,000                7.7%              253,267
Van Kampen Harbor Fund.............................            26,850,000               4.57%              150,424
Any other holder of debentures or future
  transferee, pledgee, donee or successor of any
  holder...........................................            47,659,000               8.12%              267,004
      Total........................................          $586,992,000             100.00%            3,288,495*
                                                             ============             ======             =========
</TABLE>
_____________

*     Total differs from the amount registered due to the rounding down of
      fractional shares of class B common stock issuable to each selling
      securityholder upon conversion of the debentures.

          The date of this prospectus supplement is January 19, 2001.


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission